The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
, appointment will initially be made as a Research Assistant and amended to Research Associate when the PhD is awarded. Fixed-term: This post is funded by ERC for two years in the first instance with
-
fellowships (EMBO, Marie Currie, etc.). Fixed-term: The funds for this post are available for 4 years in the first instance. About Cancer Research UK Cambridge Institute Europe's top cancer charity, Cancer
-
. Those who have submitted but not yet received their PhD will be appointed at Research Assistant level, which will be amended to Research Associate once the PhD has been awarded. Informal enquiries can be
-
Fixed-term: The funds for this post are available for 2 years in the first instance. Applications are invited for a post-doctoral research assistant/research associate position to study the
-
Fixed-term: The funds for this post are available until 31 March 2028 in the first instance. Applications are invited for a Research Laboratory Assistant with a background in plant molecular biology
-
immunology as well as a broad experimental skill set, which should include molecular and cell biology. We seek an applicant who is willing to manage research project and its administrative tasks, documentation
-
background in plant molecular biology and genetics, whose primary role will be to enable the successful operation of research projects and the smooth running of the projects for Prof. Giles Oldroyd's research
-
Europe's top cancer charity, Cancer Research UK, has combined with the University of Cambridge to fund the world class Cancer Research UK Cambridge Institute, situated on the Addenbrooke's
-
Applications are invited for a Research Associate position in the University of Cambridge, Department of Pharmacology, central Cambridge, working in the laboratory of Prof Graham Ladds. About the
-
Cancer Research UK and is a collaboration between Professor Sir Shankar Balasubramanian at Cancer Research UK's Cambridge Institute (CI) and Professor Rebecca Fitzgerald in the University of Cambridge's